1. Acute myelomonocytic leukemia and T-lymphoblastic lymphoma as simultaneous bilineage hematologic malignancy treated with decitabine: A case report
   So-Yeon Jeon et al, 2023, World Journal of Clinical Cases CrossRef
2. The landscape of alterations affecting epigenetic regulators in T‐cell acute lymphoblastic leukemia: Roles in leukemogenesis and therapeutic opportunities
   Yashna Walia et al, 2024, International Journal of Cancer CrossRef
3. Effects of post-transplant maintenance therapy with decitabine prophylaxis on the relapse for acute lymphoblastic leukemia
   Jixin Fan et al, 2023, Bone Marrow Transplantation CrossRef
4. Non-thermal plasma promotes boar sperm quality through increasing AMPK methylation
   Yaqi Li et al, 2024, International Journal of Biological Macromolecules CrossRef
5. The Synergistic Antitumor Effect of Decitabine and Vorinostat Combination on HepG2 Human Hepatocellular Carcinoma Cell Line via Epigenetic Modulation of Autophagy–Apoptosis Molecular Crosstalk
   Basant M. Salama et al, 2023, Current Issues in Molecular Biology CrossRef
6. Updates in KMT2A Gene Rearrangement in Pediatric Acute Lymphoblastic Leukemia
   Mateusz Górecki et al, 2023, Biomedicines CrossRef
7. The DNA methyltransferase inhibitor decitabine blunts the response to a high-animal fat and protein diet in mice
   José de Jesús Flores-Sierra et al, 2024, Journal of Lipid Research CrossRef
8. Orchestral role of lipid metabolic reprogramming in T-cell malignancy
   Arundhati Mehta et al, 2023, Frontiers in Oncology CrossRef